CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Mesoblast Ltd Company Snapshot
Mesoblast Ltd operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Mesoblast Ltd with three other companies in this sector in Australia: Oncosil Medical Ltd (2017 sales of 3.76 million Australian Dollars [US$2.95 million] ), Phylogica Limited (2.76 million Australian Dollars [US$2.16 million] ), and Starpharma Holdings Limited (3.65 million Australian Dollars [US$2.86 million] of which 100% was Dendritic).

Sales Analysis. Sales fell dramatically in 2017: During the year ended June of 2017, sales at Mesoblast Ltd were A$3.20 million (US$2.51 million). This is a sharp decrease of 94.5% versus 2016, when the company's sales were A$58.52 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Mesoblast Ltd
  Stock Performance Chart for Mesoblast Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (10/13/2017): 1.88
(Figures in Australian Dollars)
1 Week 21.3%   13 Weeks 36.7%  
4 Weeks -4.3%   52 Weeks 65.1%  
 
Mesoblast Ltd Key Data:
  Ticker: MSB Country: Australia
  Exchanges: OTC Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 3,198,722
(Year Ending Jan 2018).
Employees: 75
  Currency: Australian Dollars Market Cap: 806,541,645
  Fiscal Yr Ends: June Shares Outstanding: 429,011,513
  Share Type: Ordinary Closely Held Shares: 175,876,970
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.